Cannabis extract and CBD both inhibited human immune cell migration and inflammation, but the extract was more potent

Both CM5 (5% CBD cannabis extract) and pure CBD inhibited polymorphonuclear leukocyte migration, ROS production, and TNF-alpha production. CM5 was more potent than CBD alone for cell migration and TNF-alpha inhibition, but less effective for ROS suppression, suggesting other cannabis components contribute to anti-inflammatory effects.

In vitro study testing CM5 (standardized Cannabis sativa extract with 5% CBD) and pure CBD on human PMN functions: Boyden chamber migration assay, spectrofluorimetric ROS measurement, and TNF-alpha by RT-PCR and ELISA.

The finding that a whole cannabis extract outperformed pure CBD for certain immune functions adds to evidence for an entourage effect and has implications for whether patients should use isolates or full-spectrum products.

This is one of the first studies to compare a standardized cannabis extract against pure CBD using human immune cells. The differential potency across functions suggests the relationship between whole plant and isolate is more nuanced than the simple "entourage effect" narrative implies.

In vitro only (cell cultures, not in living organisms). Single extract formulation tested. The specific non-CBD components contributing to enhanced extract potency were not identified.